Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Avicenna Biosciences & Molecure S.A. Sign Collaboration for Small Molecule Drug Discovery
Details : Under the terms of the agreement, Avicenna will design algorithms to identify NCE that inhibit USP7, an attractive target in cancer that regulates the stability of crucial proteins involved in tumors.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 31, 2024
LOOKING FOR A SUPPLIER?